Compare NTWK & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTWK | DRIO |
|---|---|---|
| Founded | 1997 | 2011 |
| Country | United States | United States |
| Employees | 1460 | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.7M | 60.6M |
| IPO Year | 1997 | 2013 |
| Metric | NTWK | DRIO |
|---|---|---|
| Price | $4.52 | $7.06 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | ★ 33.5K | 5.8K |
| Earning Date | 05-15-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 316.67 | ★ 1559.02 |
| EPS | N/A | ★ 1.25 |
| Revenue | ★ $73,088,687.00 | $7,394,000.00 |
| Revenue This Year | N/A | $20.27 |
| Revenue Next Year | N/A | $47.58 |
| P/E Ratio | ★ N/A | $5.76 |
| Revenue Growth | 13.40 | ★ 43.02 |
| 52 Week Low | $2.73 | $0.38 |
| 52 Week High | $5.75 | $17.74 |
| Indicator | NTWK | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 62.54 | 39.13 |
| Support Level | $4.55 | $7.18 |
| Resistance Level | $4.86 | $9.46 |
| Average True Range (ATR) | 0.26 | 0.41 |
| MACD | -0.03 | -0.06 |
| Stochastic Oscillator | 67.72 | 20.32 |
NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.